Skip to main content

Table 4 Chemotherapy regimens received by patients in the cisplatin group

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

Type of chemotherapy Number of patients (%) N = 200
Cisplatin + Gemcitabine 58 (29)
Cisplatin + Concurrent chemoradiation 28 (14)
Cisplatin + 5-FU/Cisplatin + Capecitabine 8 (4)
Cisplatin + 5-FU + Radiation/Cisplatin + Capecitabine + Radiation 7 (3.5)
Docetaxel + Cispaltin + 5-FU 30 (15)
Epirubicin + Cisplatin + 5-FU/Epirubicin + Cisplatin 10 (5)
Docetaxel + Cispaltin + 5-FU + Cetuximab 4 (2)
DHAP (Dexamethasone + High dose ARA-C + Cisplatin) 8 (4)
Cisplatin + Etoposide/Cisplatin + Etoposide + Bleomycin 12 (6)
Cisplatin + Pemetrexed 16 (8)
Cisplatin + Navelbine 15 (7.5)
Cispaltin + Gemcitabine + Radiation 4 (2)